RSS-лента Policy papers and consultations from Medicines and Healthcare products Regulatory Agency (MHRA)

Подписчики Policy papers and consultations from Medicines and Healthcare products Regulatory Agency (MHRA) также читают

• PMDA：国際関係業務 すべて pmda.go.jp
• Swissmedic RSS Feed Content – Neu auf der Website swissmedic.ch
• 제개정고시등 mfds.go.kr
• PMDA：トップ 承認審査 pmda.go.jp
• Agency IQ agencyiq.com
• 입법/행정예고 mfds.go.kr
• ICH Public | News admin.ich.org
• Regulatory Focus | RAPS raps.org

Больше RSS-лент с сайта gov.uk

• News and communications https://www.gov.uk/search/news-and-communications.atom
• Medicines and Healthcare products Regulatory Agency - Activity on GOV.UK https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency.atom
• News and communications from Medicines and Healthcare products Regulatory Agency (MHRA) https://www.gov.uk/search/news-and-communications.atom?organisations%5B%5D=medicines-and-healthcare-products-regulatory-agency
• Alerts and recalls for drugs and medical devices https://www.gov.uk/drug-device-alerts.atom
• HM Treasury - Activity on GOV.UK https://www.gov.uk/government/organisations/hm-treasury.atom
• Russian invasion of Ukraine: UK government response - Activity on GOV.UK https://www.gov.uk/government/topical-events/russian-invasion-of-ukraine-uk-government-response.atom
• Department for Education - Activity on GOV.UK https://www.gov.uk/government/organisations/department-for-education.atom
• Department for Transport - Activity on GOV.UK https://www.gov.uk/government/organisations/department-for-transport.atom

Все RSS-ленты сайта gov.uk

Другие RSS-ленты

• ClinicalTrials.gov: Inflammatory Bowel Diseases | Phase 2, 3, 4, Not Applicable | Industry | First posted in the last 14 days clinicaltrials.gov
• ClinicalTrials.gov: "HER2+" OR "HER2-positive" OR "HER2 positive" OR ERBB2 OR "human epidermal growth factor receptor 2" OR "HER2/neu" OR "c-erbB2" | Last update posted in the last 14 days clinicaltrials.gov
• ClinicalTrials.gov: "HER2-low" OR "HER2 low" OR "HER2low" OR "HER2 expression" OR "HER2 expressor" OR "HER2 amplification" OR "HER2 amplified" OR "HER2 overexpression" OR "HER2 overexpressed" | Last update posted in the last 14 days clinicaltrials.gov